Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

biote (BTMD) Gains from Sales and Divestitures: 2022-2024

Historic Gains from Sales and Divestitures for biote (BTMD) over the last 3 years, with FY2024 value amounting to $444783.0.

  • biote's Gains from Sales and Divestitures fell 9459.53% to $24039.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $24039.0, marking a year-over-year decrease of 9459.53%. This contributed to the annual value of $444783.0 for FY2024, which is 6443.19% down from last year.
  • Per biote's latest filing, its Gains from Sales and Divestitures stood at $444783.0 for FY2024, which was down 6443.19% from $1.3 million recorded in FY2023.
  • biote's 5-year Gains from Sales and Divestitures high stood at $2.1 million for FY2022, and its period low was $444783.0 during FY2024.
  • In the last 3 years, biote's Gains from Sales and Divestitures had a median value of $1.3 million in 2023 and averaged $1.2 million.
  • Per our database at Business Quant, biote's Gains from Sales and Divestitures crashed by 3910.93% in 2023 and then plummeted by 6443.19% in 2024.
  • Over the past 3 years, biote's Gains from Sales and Divestitures (Annual) stood at $2.1 million in 2022, then tumbled by 39.11% to $1.3 million in 2023, then tumbled by 64.43% to $444783.0 in 2024.
  • Its Gains from Sales and Divestitures stands at $444783.0 for FY2024, versus $1.3 million for FY2023 and $2.1 million for FY2022.